Differentiating Juvenile Myelomonocytic Leukemia from Chronic Myeloid Leukemia in Childhood

Journal of Pediatric Hematology/Oncology

Volumn 26, Issue 4, 2004, Pages 236-242

  Chang, Yu Hsiang ^a   Jou, Shiann Tarng ^b   Lin, Dong Tsamn ^b   Lu, Meng Yao ^b   Lin, Kai Hsin ^b  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Chronic myeloid leukemia; Hematopoietic stem cell transplantation; Juvenile myelomonocytic leukemia

Indexed keywords

BUSULFAN; CYTARABINE; HYDROXYUREA; ISOTRETINOIN; MERCAPTOPURINE; PREDNISOLONE;

ARTICLE; BASOPHIL; CANCER SURVIVAL; CHILDHOOD CANCER; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; CYTOGENETICS; DIFFERENTIAL DIAGNOSIS; FEMALE; FEVER; HUMAN; JUVENILE MYELOMONOCYTIC LEUKEMIA; KARYOTYPE; LEUKOCYTE DIFFERENTIAL COUNT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; ONSET AGE; PRESCHOOL CHILD; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SURVIVAL RATE; THROMBOCYTE COUNT;

AGE OF ONSET; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INFANT; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MALE; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 16544387892     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200404000-00005     Document Type: Article

References (31)

1. Niemeyer CM, Arico M, Basso G, et al. Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. Blood. 1997;89: 3534-3543.
2. Luna-Fineman S, Shannon KM, Atwater SK, et al. Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. Blood. 1999;93:459-466.
3. Passmore SJ, Hann IM, Stiller CA, et al. Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system. Blood. 1995;85: 1742-1750.
4. Castro-Malaspina H, Schaison G, Passe S, et al. Subcute and chronic myelomonocytic leukemia in children (juvenile CML). Cancer. 1984;54: 675-686.
5. Hasle H, Arico M, Basso G, et al. Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. Leukemia. 1999;13:376-385.
6. Emanuel PD. Myelodysplastic and myeloproliferative disorders in childhood: an update. Br J Haematol. 1999;105:852-863.
7. Luna-Fineman S, Shannon KM, Lange BJ. Childhood monosomy 7: epidemiology, biology, and mechanistic implications. Blood. 1995;85:1985-1999.
8. Freedman MH, Estrov Z, Chan HSL. Juvenile chronic myelogenous leukemia. Am J Pediatr Hematol Oncol. 1988;10:261-267.
9. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835-3849.
10. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of French-American-British Cooperative Group. Ann Intern Med. 1985;103:620-625.
11. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51:189-199.
12. Cambier N, Meont ML, Fenaux P, et al. GM-CSF hypersensitivity in CD34+ purified cells in juvenile and adult chronic myelomonocytic leukemia: effect of retinoids. Blood. 1995;86:791a.
13. Niemeyer CM, Fenu S, Hasle H, et al. Differentiating juvenile myelomonocytic leukemia from infectious disease. Blood. 1998;91:365-367.
14. Smith FO, King R, Nelson G, et al. Unrelated donor bone marrow transplantation for children with juvenile myelomonocytic leukemia. Br J Haematol. 2002;116:716-724.
15. Manabe A, Okamura J, Yumura-Yagi K, et al. Allogeneic hematopoietic stem cell transplantation for 27 children with juvenile myelomonocytic leukemia diagnosed based on the criteria of International JMML Working Group. Leukemia. 2002;16:645-649.
16. Chang YH, Lu MY, Jou ST, et al. Forty-seven children suffering from chronic myeloid leukemia at a center over a 25-year period. Pediatr Hematol Oncol. 2003;20:505-515.
17. Tien HF, Wang CH, Chen YC, et al. Chromosome and bcr rearrangement in chronic myelogenous leukemia and their correlation with clinical status and prognosis of the disease. Br J Haematol. 1990;75:469-475.
18. Neuman WL, Rubin CM, Rios RB, et al. Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders. Blood. 1992;79:1501-1510.
19. Side L, Taylor B, Cayouette M, et al. Homozygous inactivating of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. N Engl J Med. 1997;336:1713-1720.
20. Side LE, Emanuel PD, Taylor B, et al. Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1. Blood. 1998;92:267-272.
21. Flotho C, Valcamonica S, Mach-Pascual S, et al. RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML). Leukemia. 1999;13:32-37.
22. Bennett JM, Catovsky D, Daniel MT, et al. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia: proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol. 1994;87:746-754.
23. Savage DG, Szydlo RM, Goldman JM. Clinical features at diagnosis in 430 patients with chronic myeloid leukemia seen at a referral center over a 16-year period. Br J Haematol. 1997;96:111-116.
24. Herrod HG, Dow LW, Sullivan JL. Persistent Epstein-Barr virus infection mimicking juvenile chronic myelogenous leukemia: immunologic and hematologic studies. Blood. 1983;61:1098-1104.
25. Kirby MA, Weitzman S, Freedman MH. Juvenile chronic myelogenous leukemia: differentiation from infantile cytomegalovirus infection. Am J Pediatr Hematol Oncol. 1990;12:292-296.
26. Lorenzana A, Lyons H, Sawaf H, et al. Human herpes virus-6 (HHV-6) infection in an infant mimicking juvenile chronic myelogenous leukemia (JCML). J Pediatr Hematol Oncol. 1997;24:136-141.
27. Honig GR, Suarez CR, Vida LN, et al. Juvenile myelomonocytic leukemia (JMML) with the hematologic phenotype of severe β thalassemia. Am J Hematol. 1998;58:67-71.
28. Hasle H, Kerndrup G, Yssing M, et al. Intensive chemotherapy in childhood myelodysplastic syndrome: a comparison with results in acute myeloid leukemia. Leukemia. 1996;10:1269-1273.
29. Festa RS, Shende A, Lanzkowsky P. Juvenile chronic myelocytic leukemia: experience with intensive combination chemotherapy. Med Pediatr Oncol. 1990;18:311-316.
30. Locatelli F, Niemeyer C, Angelucci E, et al. Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood. J Clin Oncol 1997;15:566-573.
31. Chang YH, Jou ST, Lin DT, et al. Second allogeneic hematopoietic stem-cell transplantation for juvenile myelomonocytic leukemia: case report and literature review. J Pediatr Hematol Oncol.